CfPV-2 E7 (C-Term) anticorps

N° du produit ABIN965876

1 publication est disponible pour ce produit. L’anticorps anti-CfPV-2 E7 Polyclonal produit chez le Lapin a été validé pour IHC. Il convient pour la détection de CfPV-2 E7 dans des échantillons provenant de Papillomavirus. }

Aperçu rapide pour CfPV-2 E7 (C-Term) anticorps (ABIN965876)

Antigène: CfPV-2 E7

Reactivité: Papillomavirus

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Inconjugué

Application: Immunohistochemistry (IHC)

Détail du produit

Épitope: C-Term

Immunogène: Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of Dog Canine papillomavirus 2 CfPV-2 E7 protein

Information d'application

Restrictions: For Research Use only

Stockage

Stock: 4 °C

Référence

Yuan, Ghim, Newsome, Apolinario, Olcese, Martin, Delius, Felsburg, Jenson, Schlegel: "An epidermotropic canine papillomavirus with malignant potential contains an E5 gene and establishes a unique genus." dans: Virology, Vol. 359, Issue 1, pp. 28-36, (2007) (PubMed).

Détail du antigène

Antigène: CfPV-2 E7

Classe de substances: Viral Protein

Sujet: CfPV-2 has unique biological features, it induces papillomas on footpads and interdigital regions which, if infection is persistent, can progress to highly metastatic squamous cell carcinoma. CfPV-2 does not induce oral papillomas in immunocompetent animals and antibodies generated against COPV and CfPV-2 are type-specific. The availability of a new canine papillomavirus with differing genetic and biological properties now makes it possible to study type-specific host immune responses, tissue tropism and the comparative analysis of viral gene functions in the dog.